Blood samples from vaccinated moms could help perfect GBS protection for newborns
NCT ID NCT07562061
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collects blood from 50 women in Uganda who previously received an experimental group B strep (GBS) vaccine during pregnancy. The blood is used to create quality control panels that help labs accurately measure vaccine-induced antibodies. The goal is to improve testing for GBS vaccines, which aim to prevent serious infections in newborns.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this will create reliable test panels to monitor antibody levels after GBS vaccination, helping ensure vaccines work effectively against group B strep infections in newborns.
- What could go wrong
- This is a small, early-stage lab-focused study (50 participants) that does not test a treatment or vaccine itself. The panels may not fully represent all populations or perform as expected in wider use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROUP B STREP INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MUJHU Care Ltd, Kampala
RECRUITINGKampala, Uganda